Impact of skeletal muscle index (SMI) loss during palliative systemic treatment (Tx) on time to progression and overall survival (OS) in metastatic colorectal cancer (mCRC) patients.Sophie A. Kurk, Anne M. May, Frans Erdkamp et al.|Journal of Clinical Oncology|2017Cited by 6
Impact of sarcopenia on dose limiting toxicities in metastatic colorectal cancer patients (mCRC pts) receiving palliative systemic treatmentSophie A. Kurk, Anne M. May, Petra H.M. Peeters et al.|Annals of Oncology|2017Cited by 4
Clinical added value of MRI to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): an international multicentre prospective diagnostic accuracy trialBurak Görgeç, J. Stoker, I. Hansen et al.|HPB|2024Cited by 0